The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis

Luke, 2006, Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?, Ann Intern Med, 145, 599, 10.7326/0003-4819-145-8-200610170-00139 Casadevall, 2020, The convalescent sera option for containing COVID-19, J Clin Invest, 130, 1545, 10.1172/JCI138003 Joyner, 2020, Safety update: COVID-19 convalescent plasma in 20,000 hospitalized patients, Mayo Clin Proc, 95, 1888, 10.1016/j.mayocp.2020.06.028 Joyner, 2020, Early safety indicators of COVID-19 convalescent plasma in 5,000 patients, J Clin Invest, 130, 4791, 10.1172/JCI140200 Bloch, 2020, Deployment of convalescent plasma for the prevention and treatment of COVID-19, J Clin Invest, 130, 2757, 10.1172/JCI138745 Piechotta, 2020, Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review, Cochrane Database Syst Rev, 7, CD013600 Chai, 2020, Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review, Cochrane Database Syst Rev, 10, CD013600 Li, 2020, Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients with Severe and Life-threatening COVID-19: A Randomized Clinical Trial, JAMA, 324, 460, 10.1001/jama.2020.10044 Gharbharan Salazar, 2020, Treatment of coronavirus disease 2019 patients with convalescent plasma reveals a signal of significantly decreased mortality, Am J Pathol, 190, 2290, 10.1016/j.ajpath.2020.08.001 Hartman, 2020, Hospitalized COVID-19 patients treated with convalescent plasma in a mid-size city in the midwest, Transl Med Commun, 5, 17, 10.1186/s41231-020-00068-9 Abolghasemi, 2020, Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: results of a multicenter clinical study, Transfus Apher Sci, 59, 102875, 10.1016/j.transci.2020.102875 Rasheed, 2020, The therapeutic effectiveness of convalescent plasma therapy on treating critically-ill COVID-19 patients residing in respiratory care units in hospitals in Baghdad, Iraq, Infez Med, 28, 357 Avendano-Sola Sterne, 2019, RoB 2: a revised tool for assessing risk of bias in randomised trials, BMJ, 366, l4898, 10.1136/bmj.l4898 Higgins, 2020, Chapter 8: Assessing risk of bias in a randomized trial Wells Murad, 2018, Methodological quality and synthesis of case series and case reports, BMJ Evid Based Med, 23, 60, 10.1136/bmjebm-2017-110853 DerSimonian, 1986, Meta-analysis in clinical trials, Control Clin Trials, 7, 177, 10.1016/0197-2456(86)90046-2 Schunemann, 2020, Chapter 15: Interpretting results and drawing conclusions Schunemann, 2020, Chapter 14: Completing ‘summary of findings’ tables and grading the certainty of the evidence AlQahtani Libster, 2021, Early high-titer plasma therapy to prevent severe Covid-19 in older adults, N Engl J Med, 384, 610, 10.1056/NEJMoa2033700 Ray Simonovich, 2021, A randomized trial of convalescent plasma in Covid-19 severe pneumonia, N Engl J Med, 384, 619, 10.1056/NEJMoa2031304 Agarwal, 2020, Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial) [erratum appears in BMJ. 2020;371:m4232], BMJ, 371, m3939, 10.1136/bmj.m3939 Bajpai Duan, 2020, Effectiveness of convalescent plasma therapy in severe COVID-19 patients, Proc Natl Acad Sci U S A, 117, 9490, 10.1073/pnas.2004168117 Salazar, 2021, Significantly decreased mortality in a large cohort of COVID-19 patients transfused early with convalescent plasma containing high-titer anti–severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein IgG, Am J Pathol, 191, 90, 10.1016/j.ajpath.2020.10.008 Xia, 2020, Improved clinical symptoms and mortality on severe/critical COVID-19 patients utilizing convalescent plasma transfusion, Blood, 136, 755, 10.1182/blood.2020007079 AlShehry, 2021, Safety and efficacy of convalescent plasma for severe COVID-19: interim report of a multicenter phase II study from Saudi Arabia, Saudi J Med Med Sci, 9, 16, 10.4103/sjmms.sjmms_731_20 Budhiraja ah Yoon, 2021, Treatment of severe COVID-19 with convalescent plasma in the Bronx, NYC, JCI Insight, 6, e142270 Rogers Altuntas, 2020, Convalescent plasma therapy in patients with COVID-19, Transfus Apher Sci, 102955 Klapholz, 2021, Matched cohort study of convalescent COVID-19 plasma (CCP) treatment in severely or life threateningly ill COVID-19 patients, Open Forum Infect Dis, 8, ofab001, 10.1093/ofid/ofab001 Klein Perotti, 2020, Covid-19 Plasma Task Force. Mortality reduction in 46 severe Covid-19 patients treated with hyperimmune plasma. A proof of concept single arm multicenter trial, Haematologica, 105, 2834, 10.3324/haematol.2020.261784 Moniuszko-Malinowska, 2021, Convalescent plasma transfusion for the treatment of COVID-19—experience from Poland: a multicenter study, J Clin Med, 10, 28 Omrani, 2021, Convalescent plasma for the treatment of patients with severe coronavirus disease 2019: a preliminary report, J Med Virol, 93, 1678, 10.1002/jmv.26537 Hegerova, 2020, Use of convalescent plasma in hospitalized patients with COVID-19: case series, Blood, 136, 759, 10.1182/blood.2020006964 Alsharidah, 2021, COVID-19 convalescent plasma treatment of moderate and severe cases of SARS-CoV-2 infection: a multicenter interventional study, Int J Infect Dis, 103, 439, 10.1016/j.ijid.2020.11.198 Zeng, 2020, Effect of convalescent plasma therapy on viral shedding and survival in patients with coronavirus disease 2019, J Infect Dis, 222, 38, 10.1093/infdis/jiaa228 Donato Salazar Liu, 2020, Convalescent plasma treatment of severe COVID-19: a propensity score–matched control study, Nat Med, 26, 1708, 10.1038/s41591-020-1088-9 Joyner, 2021, Convalescent plasma antibody levels and the risk of death from Covid-19, N Engl J Med, 10.1056/NEJMoa2031893 Maor, 2020, Compassionate use of convalescent plasma for treatment of moderate and severe pneumonia in COVID-19 patients and association with IgG antibody levels in donated plasma, EClinicalMedicine, 26, 100525, 10.1016/j.eclinm.2020.100525 Baang, 2021, Prolonged severe acute respiratory syndrome coronavirus 2 replication in an immunocompromised patient, J Infect Dis, 223, 23, 10.1093/infdis/jiaa666 Balashov, 2020, SARS-CoV-2 convalescent plasma therapy in pediatric patient after hematopoietic stem cell transplantation, Transfus Apher Sci, 102983 Bao, 2020, Clinical features of COVID-19 in a young man with massive cerebral hemorrhage—case report, SN Compr Clin Med, 1 Betrains, 2020, Convalescent plasma treatment of persistent severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with lymphoma with impaired humoral immunity and lack of neutralising antibodies, Br J Haematol Bhumbra, 2020, Clinical features of critical coronavirus disease 2019 in children, Pediatr Crit Care Med, 21, e948, 10.1097/PCC.0000000000002511 Ilona, 2020, Successful administration of convalescent plasma in critically ill COVID-19 patients in Hungary: the first two cases, Orv Hetil, 161, 1111 Bradfute, 2020, Severe acute respiratory syndrome coronavirus 2 neutralizing antibody titers in convalescent plasma and recipients in New Mexico: an open treatment study in patients with coronavirus disease 2019, J Infect Dis, 222, 1620, 10.1093/infdis/jiaa505 Choudhury, 2020, COVID-19 in liver transplant recipients—a series with successful recovery, J Clin Transl Hepatol, 8, 467 Christensen, 2020, Coronavirus disease 2019 viremia, serologies, and clinical course in a case series of transplant recipients, Transplant Proc, 52, 2637, 10.1016/j.transproceed.2020.08.042 Çınar, 2020, Convalescent (immune) plasma treatment in a myelodysplastic COVID-19 patient with disseminated tuberculosis, Transfus Apher Sci, 59, 102821, 10.1016/j.transci.2020.102821 Clark, 2020, Convalescent plasma for persisting COVID-19 following therapeutic lymphocyte depletion: a report of rapid recovery, Br J Haematol, 190, e154, 10.1111/bjh.16981 Diorio, 2020, Convalescent plasma for pediatric patients with SARS-CoV-2–associated acute respiratory distress syndrome, Pediatr Blood Cancer, 67, e28693, 10.1002/pbc.28693 Donzelli, 2020, Prone positioning and convalescent plasma therapy in a critically ill pregnant woman with COVID-19, Clin Case Rep, 8, 3352, 10.1002/ccr3.3426 Dulipsingh, 2020, SARS-CoV-2 serology and virology trends in donors and recipients of convalescent plasma, Transfus Apher Sci, 59, 102922, 10.1016/j.transci.2020.102922 Easterlin, 2020, Extremely preterm infant born to a mother with severe COVID-19 pneumonia, J Investig Med High Impact Case Rep, 8 Einollahi, 2020, A patient affected by critical COVID-19 pneumonia, successfully treated with convalescent plasma, Transfus Apher Sci, 59, 102995, 10.1016/j.transci.2020.102995 Erkurt, 2020, Life-saving effect of convalescent plasma treatment in Covid-19 disease: clinical trial from eastern Anatolia, Transfus Apher Sci, 59, 102867, 10.1016/j.transci.2020.102867 Ferrari, 2021, Convalescent hyperimmune plasma for chemo-immunotherapy induced immunodeficiency in COVID-19 patients with hematological malignancies, Leuk Lymphoma, 1 Figlerowicz, 2020, First case of convalescent plasma transfusion in a child with COVID-19–associated severe aplastic anemia, Transfus Apher Sci, 59, 102866, 10.1016/j.transci.2020.102866 Fisher, 2021, Rapid recovery of taste and smell in a patient with SARS-CoV-2 following convalescent plasma therapy, QJM, hcaa341, 10.1093/qjmed/hcaa341 Fung, 2020, Treatment of immunocompromised COVID-19 patients with convalescent plasma, Transpl Infect Dis, e13477 Gazitúa Gemici, 2020, A single center cohort of 40 severe COVID-19 patients who were treated with convalescent plasma, Turk J Med Sci, 50, 1781, 10.3906/sag-2009-77 González, 2020, [Convalescent plasma therapy in COVID-19 patients, in the Province of Buenos Aires], Medicina (B Aires), 80, 417 Hahn, 2020, [Patient with severe covid-19 treated with convalescent plasma], Tidsskr Nor Laegeforen, 140 Hartman, 2020, Use of COVID-19 convalescent plasma as prophylaxis in a patient with new onset ALL, Clin Oncol Case Rep, 4 Hatzl, 2020, Response to “COVID-19 in persons with haematological cancers, Leukemia, 34, 2265, 10.1038/s41375-020-0914-x Hovey, 2020, Burton’s agammaglobulinemia and COVID-19, Cureus, 12, e11701 Hu, 2020, Effectiveness of convalescent plasma therapy for COVID-19 patients in Hunan, China, Dose-Response, 18, 10.1177/1559325820979921 Huang, 2020, A retrospective study on the effects of convalescent plasma therapy in 24 patients diagnosed with COVID-19 pneumonia in February and March 2020 at 2 centers in Wuhan, China, Med Sci Monit, 26, e928755 Abid, 2020, Bronchoalveolar lavage–based COVID-19 testing in patients with cancer, Hematol Oncol Stem Cell Ther, S1658-3876 Hueso, 2020, Convalescent plasma therapy for B-cell depleted patients with protracted COVID-19 disease, Blood, 136, 2290, 10.1182/blood.2020008423 Im, 2020, Convalescent plasma therapy in coronavirus disease 2019: a case report and suggestions to overcome obstacles, J Korean Med Sci, 35, e239, 10.3346/jkms.2020.35.e239 Jaiswal, 2020, Therapeutic plasma exchange followed by convalescent plasma transfusion in critical COVID-19—an exploratory study, Int J Infect Dis, 102, 332, 10.1016/j.ijid.2020.10.085 Jamir, 2020, Convalescent plasma therapy and remdesivir duo successfully salvaged an early liver transplant recipient with severe COVID-19 pneumonia, Ann Hepatobiliary Pancreat Surg, 24, 526, 10.14701/ahbps.2020.24.4.526 Jamous, 2020, Critical illness due to Covid-19: a description of the surge in a single center in Sioux Falls, S D Med, 73, 312 Ji, 2021, Use of convalescent plasma therapy in eight mild COVID-19 patients, New Microbes New Infect, 39, 100814, 10.1016/j.nmni.2020.100814 Jiang, 2020, Convalescent plasma therapy: helpful treatment of COVID-19 in a kidney transplant recipient presenting with severe clinical manifestations and complex complications, Clin Transplant, 34, e14025, 10.1111/ctr.14025 Jin Jin, 2020, Three patients with X-linked agammaglobulinemia hospitalized for COVID-19 improved with convalescent plasma, J Allergy Clin Immunol Pract, 8, 3594, 10.1016/j.jaip.2020.08.059 Karataş, 2020, Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma, Transfus Apher Sci, 59, 102871, 10.1016/j.transci.2020.102871 Ahn, 2020, Use of convalescent plasma therapy in two covid-19 patients with acute respiratory distress syndrome in Korea, J Korean Med Sci, 35, e149, 10.3346/jkms.2020.35.e149 Katz-Greenberg, 2020, Outcomes of COVID-19–positive kidney transplant recipients: a single-center experience, Clin Nephrol, 94, 318, 10.5414/CN110311 Kong, 2020, Successful treatment of a centenarian with coronavirus disease 2019 (COVID-19) using convalescent plasma, Transfus Apher Sci, 59, 102820, 10.1016/j.transci.2020.102820 Lancman, 2020, Severe COVID-19 virus reactivation following treatment for B cell acute lymphoblastic leukemia, J Hematol Oncol, 13, 131, 10.1186/s13045-020-00968-1 Lima, 2020, COVID-19 in recent heart transplant recipients: clinicopathologic features and early outcomes, Transpl Infect Dis, 22, e13382, 10.1111/tid.13382 Luetkens, 2020, Successful transfer of anti–SARS-CoV-2 immunity using convalescent plasma in an MM patient with hypogammaglobulinemia and COVID-19, Blood Adv, 4, 4864, 10.1182/bloodadvances.2020002595 London, 2021, Severe COVID-19 in patients with B cell alymphocytosis and response to convalescent plasma therapy, J Clin Immunol, 41, 356, 10.1007/s10875-020-00904-5 Lubnow, 2021, Secondary hemophagocytic lymphohistiocytosis and severe liver injury induced by hepatic SARS-CoV-2 infection unmasking Wilson’s disease: balancing immunosuppression, Int J Infect Dis, 103, 624, 10.1016/j.ijid.2020.12.047 Malsy, 2020, Sustained response after remdesivir and convalescent plasma therapy in a B-cell depleted patient with protracted COVID-19, Clin Infect Dis, ciaa1637, 10.1093/cid/ciaa1637 Martinez-Resendez Mehta, 2021, Incidence and outcomes of COVID-19 in kidney and liver transplant recipients with HIV: report from the National HOPE in Action Consortium, Transplantation, 105, 216, 10.1097/TP.0000000000003527 Anderson, 2020, The use of convalescent plasma therapy and remdesivir in the successful management of a critically ill obstetric patient with novel coronavirus 2019 infection: a case report, Case Rep Womens Health, 27, e00221, 10.1016/j.crwh.2020.e00221 Milošević, 2020, Atypical course of COVID-19 in patient with Bruton agammaglobulinemia, J Infect Dev Ctries, 14, 1248, 10.3855/jidc.13840 Mira, 2020, Rapid recovery of a SARS-CoV-2–infected X-linked agammaglobulinemia patient after infusion of COVID-19 convalescent plasma, J Allergy Clin Immunol Pract, 8, 2793, 10.1016/j.jaip.2020.06.046 Moore, 2020, A 63-year-old woman with a history of non-Hodgkin lymphoma with persistent SARS-CoV-2 infection who was seronegative and treated with convalescent plasma, Am J Case Rep, 21, e927812, 10.12659/AJCR.927812 Naeem, 2020, Successful recovery from COVID-19 in three kidney transplant recipients who received convalescent plasma therapy, Transpl Infect Dis, e13451 Niu, 2020, COVID-19 in allogeneic stem cell transplant: high false-negative probability and role of CRISPR and convalescent plasma, Bone Marrow Transplant, 55, 2354, 10.1038/s41409-020-0972-8 Olivares-Gazca, 2020, Infusion of convalescent plasma is associated with clinical improvement in critically ill patients with COVID-19: a pilot study, Rev Invest Clin, 72, 159 Pal, 2020, Safety and efficacy of COVID-19 convalescent plasma in severe pulmonary disease: a report of 17 patients, Transfus Med Peng, 2020, Management and treatment of COVID-19: the Chinese experience, Can J Cardiol, 36, 915, 10.1016/j.cjca.2020.04.010 Ragab, 2021, A case of COVID-19, with cytokine storm, treated by consecutive use of therapeutic plasma exchange followed by convalescent plasma transfusion: a case report, J Med Virol, 93, 1854, 10.1002/jmv.26630 Rahman, 2020, COVID-19 outbreak and emerging management through pharmaceutical therapeutic strategy, Curr Pharm Des, 26, 5224, 10.2174/1381612826666200713174140 Antony, 2020, Early use of tocilizumab in respiratory failure associated with acute COVID-19 pneumonia in recipients with solid organ transplantation, IDCases, 21, e00888, 10.1016/j.idcr.2020.e00888 Rizvi, 2021, Cytosorb filter: an adjunct for survival in the COVID-19 patient in cytokine storm? A case report, Heart Lung, 50, 44, 10.1016/j.hrtlng.2020.09.007 Rodriguez, 2020, COVID-19 convalescent plasma clears SARS-CoV-2 refractory to remdesivir in an infant with congenital heart disease, Blood Adv, 4, 4278, 10.1182/bloodadvances.2020002507 Schwartz, 2020, Extracorporeal membrane oxygenation for COVID-19–associated multisystem inflammatory syndrome in a 5-year-old, Am Surg, 10.1177/0003134820983198 Shankar, 2020, Convalescent plasma to aid in recovery of COVID-19 pneumonia in a child with acute lymphoblastic leukemia, Transfus Apher Sci. Published online, 102956 Shen, 2020, Treatment of 5 critically ill patients with COVID-19 with convalescent plasma, JAMA, 323, 1582, 10.1001/jama.2020.4783 Szwebel, 2021, Usefulness of plasma SARS-CoV-2 RNA quantification by droplet-based digital PCR to monitor treatment against COVID-19 in a B-cell lymphoma patient, Stem Cell Rev Rep, 17, 296, 10.1007/s12015-020-10107-5 Tan, 2020, A special case of COVID-19 with long duration of viral shedding for 49 days. medRxiv, March, 27 Tremblay, 2020, Convalescent plasma for the treatment of severe COVID-19 infection in cancer patients, Cancer Med, 9, 8571, 10.1002/cam4.3457 Trimarchi, 2020, Eculizumab, SARS-CoV-2 and atypical hemolytic uremic syndrome, Clin Kidney J, 13, 739, 10.1093/ckj/sfaa166 Van Damme, 2020, Case report: convalescent plasma, a targeted therapy for patients with CVID and severe COVID-19, Front Immunol, 11, 596761, 10.3389/fimmu.2020.596761 van Oers, 2021, SARS-CoV-2 infection associated with hepatitis in an infant with X-linked severe combined immunodeficiency, Clin Immunol, 224, 108662, 10.1016/j.clim.2020.108662 Vlachogianni, 2020, A case of COVID-19 convalescent plasma donation in Greece: directed donation for compassionate use in the donor’s critically ill father, Transfus Clin Biol, 27, 269, 10.1016/j.tracli.2020.09.001 Wang, 2020, Convalescent plasma therapy in critically ill coronavirus disease 2019 patients with persistently positive nucleic acid test, case series report, Medicine (Baltimore), 99, e21596, 10.1097/MD.0000000000021596 Wang, 2020, A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward, J Hematol Oncol, 13, 94, 10.1186/s13045-020-00934-x Wei, 2020, Long-term positive severe acute respiratory syndrome coronavirus 2 ribonucleic acid and therapeutic effect of antivirals in patients with coronavirus disease: case reports, Rev Soc Bras Med Trop, 53, e20200372, 10.1590/0037-8682-0372-2020 Wright, 2021, Successful use of COVID-19 convalescent plasma in a patient recently treated for follicular lymphoma, Clin Lymphoma Myeloma Leuk, 21, 66, 10.1016/j.clml.2020.06.012 Xu, 2020, Role of adjunctive treatment strategies in COVID-19 and a review of international and national clinical guidelines, Mil Med Res, 7, 22 Yang, 2020, Inflammatory cytokine depletion in severe coronavirus disease 2019 infectious pneumonia: a case report, Medicine (Baltimore), 99, e23449, 10.1097/MD.0000000000023449 Ye, 2020, Treatment with convalescent plasma for COVID-19 patients in Wuhan, China, J Med Virol, 92, 1890, 10.1002/jmv.25882 Yi, 2020, Early experience with COVID-19 and solid organ transplantation at a US high-volume transplant center, Transplantation, 104, 2208, 10.1097/TP.0000000000003339 Avanzato, 2020, Case study: prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised individual with cancer, Cell, 183, 1901, 10.1016/j.cell.2020.10.049 Yokoyama Zeng, 2020, The efficacy assessment of convalescent plasma therapy for COVID-19 patients: a multi-center case series, Signal Transduct Target Ther, 5, 219, 10.1038/s41392-020-00329-x Zhang, 2020, Treatment with convalescent plasma for critically ill patients with severe acute respiratory syndrome coronavirus 2 infection, Chest, 158, e9, 10.1016/j.chest.2020.03.039 Zhang, 2020, Convalescent plasma rescued a severe COVID-19 patient with chronic myeloid leukemia blast crisis and myelofibrosis, Turk J Haematol Zhang, 2020, Successful recovery of COVID-19–associated recurrent diarrhea and gastrointestinal hemorrhage using convalescent plasma, Mil Med Res, 7, 45 Zhang, 2020, Anti–SARS-CoV-2 virus antibody levels in convalescent plasma of six donors who have recovered from COVID-19, Aging (Albany NY), 12, 6536, 10.18632/aging.103102 Joyner Senefeld Murad, 2017, Clinical practice guidelines: a primer on development and dissemination, Mayo Clin Proc, 92, 423, 10.1016/j.mayocp.2017.01.001 Cheng, 2005, Use of convalescent plasma therapy in SARS patients in Hong Kong, Eur J Clin Microbiol Infect Dis, 24, 44, 10.1007/s10096-004-1271-9 Hung, 2011, Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection, Clin Infect Dis, 52, 447, 10.1093/cid/ciq106 Robbiani, 2020, Convergent antibody responses to SARS-CoV-2 in convalescent individuals, Nature, 584, 437, 10.1038/s41586-020-2456-9 Klein, 2020, Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population, J Clin Invest, 130, 6141, 10.1172/JCI142004 Imai, 2020, Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development, Proc Natl Acad Sci U S A, 117, 16587, 10.1073/pnas.2009799117 Sun, 2020, Generation of a broadly useful model for COVID-19 pathogenesis, vaccination, and treatment, Cell, 182, 734, 10.1016/j.cell.2020.06.010 Bandopadhyay, 2021, Nature and dimensions of the systemic hyper-inflammation and its attenuation by convalescent plasma in severe COVID-19, J Infect Dis, jiab010 Casadevall, 1995, Return to the past: the case for antibody-based therapies in infectious diseases, Clin Infect Dis, 21, 150, 10.1093/clinids/21.1.150